Publication:
Elevated SUVmax on gallium-68-PSMA-11 PET (PSMA-PET) is associated with shorter radiographic progression-free survival (rPFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC)

dc.contributor.coauthorKapar, C.
dc.contributor.coauthorArslan, E.
dc.contributor.coauthorGültürk, İ.
dc.contributor.coauthorPolat, M.
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorTural, Deniz
dc.contributor.kuauthorKıkılı, Cevat İlteriş
dc.contributor.kuauthorYağmur, Feyyaz Hazar
dc.contributor.kuauthorKöylü, Bahadır
dc.contributor.kuauthorKemik, Fatih
dc.contributor.kuauthorEsen, Buğra Han
dc.contributor.kuauthorSelçukbiricik, Fatih
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.date.accessioned2026-08-14T11:21:55Z
dc.date.issued2025
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.ScopusPercentile98
dc.identifier.ScopusQuartileQ1
dc.identifier.WoSPercentile99,2
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/j.annonc.2025.08.3023
dc.identifier.eissn1569-8041
dc.identifier.embargoN/A
dc.identifier.issn0923-7534
dc.identifier.urihttp://doi.org/10.1016/j.annonc.2025.08.3023
dc.identifier.urihttps://hdl.handle.net/20.500.14288/34407
dc.identifier.volume36
dc.identifier.wos001633184200120
dc.keywordsProstate cancer
dc.keywordsRadiography
dc.keywordsOverall survival
dc.keywordsSurvival analysis
dc.keywordsClinical significance
dc.keywordsRetrospective cohort study
dc.keywordsProportional hazards model
dc.keywordsCancer
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofAnnals of Oncology
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectHealth sciences
dc.subjectMedicine
dc.subjectOncology
dc.titleElevated SUVmax on gallium-68-PSMA-11 PET (PSMA-PET) is associated with shorter radiographic progression-free survival (rPFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC)
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files